Rezultati pretraživanja
  1. Do get in touch if you have any questions! Look forward to chatting with you about your ideas and how Panacea Stars can work with you to deliver your research to benefit patients!

    Prikaži ovu nit
  2. prije 3 sata

    🔊Did you know that Andrew Tsourkas from the University of Pennsylvania will speak at ? 🙌 Join him to discuss engineering and to enable efficient cytosolic delivery with cationic lipids: 👉

  3. prije 3 sata

    [] is based on innovative expertise in glycoengineering. The company develops with serum-like glycosylation for , or use. > >

  4. prije 6 sati
  5. Prof. Alastair Stewart will discuss challenges in successful development of for lung diseases at our 4 March event

  6. “Buzz on the Street” Show: Q BioMed (OTCQB: ) Mannin Research to Potentially Treat Coronavirus (Sponsored Financial News Content)

  7. research has showed the structure of the B M2 proton channel, which the team hope can aid in the development of targeted to treat the condition. Click here to read more:

  8. prije 21 sat
  9. 4. velj

    Cancer cells' unique metabolism allows them to thrive in nutrient poor environments & maximize cell proliferation, but might also present an opportunity for targeted . Read more in our collection on

    Prikaži ovu nit
  10. 4. velj

    - Tremendous has been made to beat with , early and new . “Cancer is no longer a death sentence, but still a long way is needed to guarantee to ". Prof Meunier, Vice-President of .

  11. 1. velj
  12. Read about our work on modeling peptide targeting EphB4 that got published recently! ⁩ ⁦

  13. 30. sij

    Cutting Edge Symposia - Challenges & opportunities for "ex vivo" model systems - . An excellent program with national & international leaders in the field. Strongly recommend, student reg option. 70 spots only!

  14. 29. sij

    In medicine dialysis is the process of removing excess water, solutes, and toxins from the blood in people whose kidneys can no longer perform these functions naturally. This is referred to as renal replacement therapy Journal of

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.